J Leg Med. 2020 Jul-Dec;40(3-4):321-333. doi: 10.1080/01947648.2020.1868939.
This article describes the impact of the 2009 Family Smoking and Prevention Tobacco Control Act (TCA) on local tobacco control through the lens of New York City's experience during the first 10 years after the TCA was enacted, highlighting one meaningful change and an opportunity that has failed to materialize. Much of the analysis regarding the TCA highlights the U.S. Food and Drug Administration's (FDA) new powers and the TCA's impact on a national level. However, the TCA also opened up opportunities for local governments to pursue sound tobacco control policies that previously seemed fraught with high legal risk. This article focuses on two aspects of the TCA. First, the TCA weakened one of the tobacco industry's most reliable litigation weapons-preemption. Second, the TCA authorized the FDA to combat the illicit trade of tobacco products. Despite clear language in the TCA, the FDA has not signaled an inclination to take action regarding illicit trade in the context of tobacco tax evasion.
本文通过描述纽约市在《家庭吸烟预防和烟草控制法案》(TCA)颁布后的头 10 年中的经验,从新的视角探讨了该法案对地方烟草控制的影响,重点介绍了一项有意义的变革和一个未能实现的机遇。关于 TCA 的大部分分析都强调了美国食品和药物管理局(FDA)的新权力以及 TCA 在国家层面上的影响。然而,TCA 也为地方政府提供了机会,使他们能够采取先前似乎存在高法律风险的合理烟草控制政策。本文重点关注 TCA 的两个方面。首先,TCA 削弱了烟草业最可靠的诉讼武器之一——预先裁定。其次,TCA 授权 FDA 打击烟草制品的非法贸易。尽管 TCA 中有明确的语言,但 FDA 并未表示倾向于就烟草逃税背景下的非法贸易采取行动。